Company: BDRX
Filing Date: 2025-06-13
Form Type: 424B3
Source: 0001214659-25-009214
Chunk: 88

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-06-13
Form: 424B3
Chunk 88
---
rogated by the creation or issue of any new shares ranking in priority to or pail passu with or subsequent to such shares; and |

| 69 |

| (2) | Neither. |

| (a) | the passing by the Company of any resolution for the cancellation of the C Deferred                                                     
 Shares (whether for no consideration or otherwise) by means of a reduction of capital (whether or not requiring the confirmation of the 
 Court) nor the obtaining by the Company nor the making by the Court of any order confirming any such reduction of capital nor any such  
 order becoming effective; nor                                                                                                           |

| (b) | the purchase by the Company in accordance with the Act of any of its own shares 
 or securities (or the passing of a resolution to permit any such purchase); nor |

| (c) | any other reduction of share capital including without limitation the reduction                                                            
 of any share premium account of the Company, shall constitute a variation, modification or abrogation of the rights attaching to the C     
 Deferred Shares and the C Deferred Shares may at any time be cancelled (whether for no consideration or otherwise) by means of a reduction 
 of capital or repurchased in either case in accordance with the Act without the sanction or other consent of the holders of the C Deferred 
 Shares.                                                                                                                                    |

| (E) | Share certificates |

Notwithstanding any other provision
of the Articles and unless specifically required by the provisions of the Act, the Company shall not be required to issue any certificate
in respect of the C Deferred Shares.

| 145.2 | At any time after the adoption of these Articles: |

| (A) | The Company shall have irrevocable authority to appoint any person on behalf of                                                       
 any holder of C Deferred Shares to enter into an agreement to transfer such C Deferred Shares to such other person (whether or not an 
 officer of the Company) as the Board may determine to act as the custodian thereof; and/or                                            |

| (B) | The Board may convene a general meeting of the Company in accordance with Section                                                            
 694 of the Act, for the purpose of considering and, if thought fit, passing a resolution to authorise the terms of a contract for the        
 purchase by the Company of any or all of the C Deferred Shares. The terms of such contract shall provide for payment in full of the purchase 
 price upon completion and may require the holders of the C Deferred Shares concerned to sell such shares for a price not exceeding 1 penny